top of page

Extracellular Communication

Mercury Bio has harnessed the power of extracellular communication via the creation of a yeast-derived, highly targeted drug delivery platform. This platform unleashes the potential for new medicines and vaccines to treat previously untreatable diseases and accelerate healing. 

See how the RDC 2021 & 2024 Technology & Manufacturing (TEAM) Fund awards helped Mercury Bio/Spartina Biotechnologies in its pre-patent preparation days during the COVID pandemic and its current expansion and commercialization phase.

For more information on our Technology & Manufacturing (TEAM) Fund:


bottom of page